Find in Library

Medicinal plants have traditionally been used to treat various human diseases worldwide. In this study, we evaluated the leaf extracts of plants from the Acanthaceae family, specifically <i>Clinacanthus nutans</i> (Burm.f.) Lindau, <i>Thunbergia laurifolia</i> Lindl., and <i>Acanthus ebracteatus</i> Vahl., for their compounds and antioxidant activity. The ethanolic extracts of <i>A. ebracteatus</i> showed the highest total phenolic content at 22.55 mg GAE/g extract and the strongest antioxidant activities, with IC₅₀ values of 0.24 mg/mL and 3.05 mg/mL, as determined by DPPH and ABTS assays. The antibacterial efficacy of these extracts was also tested against <i>Streptococcus pyogenes</i>, <i>Streptococcus mutans</i>, <i>Staphylococcus aureus</i>, and <i>Klebsiella pneumoniae</i>. The diameters of the inhibition zones ranged from 14.7 to 17.3 mm using the agar well diffusion method, with MIC and MBC values ranging from 7.81 to 250 mg/mL. Anti-biofilm formation, antibacterial adhesion, and antibacterial invasion assays further demonstrated that these medicinal plant extracts can inhibit bacterial biofilm formation and prevent the adhesion and invasion of oral pathogenic bacteria on the human tongue squamous cell carcinoma-derived cell line (HSC-4 cells). The ethanolic extracts of <i>C. nutans</i> and <i>A. ebracteatus</i> were able to inhibit the <i>gtfD</i> and <i>gbp</i> genes, which facilitate biofilm formation and bacterial adherence to surfaces. These findings provide new insights into the antibacterial and antioxidant properties of plant extracts from the Acanthaceae family. These activities could enhance the clinical and pharmaceutical applications of plant extracts as an alternative therapy for bacterial infections and a dietary supplement.